Author

Rick G. Schnellmann

University of ArizonaORCID 0000-0001-7518-0876Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Approach:statistical model· 3 Research Focus:differential expression· 2 Assay:bulk RNA-seq· 1 Assay:metabolomics· 1

Frequent Co-Authors

Danielle A. BeckteliD· 3 shared Kristian P. DoyleiD· 3 shared Marco A. Tavera-Garcia· 3 shared Frankie G. GarciaiD· 2 shared Jacob C. ZbeskoiD· 2 shared Kylie Calderon· 2 shared Thuy‐Vi V. NguyeniD· 2 shared Amanda G. Chung· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Danielle A. BecktelORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeurosciencebioRxivPreprintMar 22, 2022

Increased fatty acid metabolism and decreased glycolysis are hallmarks of metabolic reprogramming in the brain during recovery from experimental stroke

Sanna H. Loppi, Marco A. Tavera-Garcia, Danielle A. Becktel…·Kristian P. Doyle

2 citations

mousemetabolomics

𝕏 PostBluesky

NeuroscienceJournal of Pharmacology and Experimental TherapeuticsPeer-reviewedDec 10, 2021

Post-stroke administration of the p75 neurotrophin receptor modulator, LM11A-31, attenuates chronic changes in brain metabolism, increases neurotransmitter levels, and improves recovery

Thuy‐Vi V. Nguyen, Rachel H. Crumpacker, Kylie Calderon…·Kristian P. Doyle

This study shows that LM11A-31, a p75NTR modulator, improves stroke recovery by enhancing brain metabolism, neurotransmitter levels, and reducing neurodegeneration in mice.

15 citations

mousestatistical model

𝕏 PostBluesky

NeuroscienceJournal of NeurosciencePeer-reviewedNov 24, 2021

Repeated administration of 2-hydroxypropyl-β-cyclodextrin (HPβCD) attenuates the chronic inflammatory response to experimental stroke

Danielle A. Becktel, Jacob C. Zbesko, Jennifer B. Frye…·Kristian P. Doyle

This study shows that repeated HPβCD treatment reduces chronic inflammation and cognitive decline after stroke by modulating lipid metabolism and immune responses.

40 citations

mousebulk RNA-seq

𝕏 PostBluesky